DSpace@İnönü

Yazar "Tabak, F." için listeleme

Yazar "Tabak, F." için listeleme

Sırala: Sıra: Sonuçlar:

  • Port-related Delftia tsuruhatensis bacteremia in a patient with breast cancer 
    Tabak, O.; Mete, B.; Aydin, S.; Mandel, N.M.; Otlu, B.; Ozaras, R.; Tabak, F. (2013)
    Delftia tsuruhatensis is a non-glucose fermenting, oxidase positive, motile, gram-negative bacillus first isolated from activated sludge collected from a domestic wastewater treatment plant in Japan. To the best of our ...
  • Withdrawal of Staphylococcus aureus from intensive care units in Turkey 
    Erdem, H.; Dizbay, M.; Karabey, S.; Kaya, S.; Demirdal, T.; Koksal, I.; Inan, A.; Erayman, I.; Ak, O.; Ulu-Kilic, A.; Karasahin, O.; Akbulut, A.; Elaldi, N.; Yilmaz, G.; Candevir, A.; Gul, H.C.; Gonen, I.; Oncul, O.; Aslan, T.; Azak, E.; Tekin, R.; Kocak Tufan, Z.; Yenilmez, E.; Arda, B.; Gungor, G.; Cetin, B.; Kose, S.; Turan, H.; Akalin, H.; Karabay, O.; Dogan-Celik, A.; Albayrak, A.; Guven, T.; Celebi, G.; Ozgunes, N.; Ersoy, Y.; Sirmatel, F.; Oztoprak, N.; Balkan, I.I.; Bayazit, F.N.; Ucmak, H.; Oncu, S.; Ozdemir, D.; Ozturk-Engin, D.; Bitirgen, M.; Tabak, F.; Akata, F.; Willke, A.; Gorenek, L.; Ahmed, S.S.; Tasova, Y.; Ulcay, A.; Dayan, S.; Esen, S.; Leblebicioglu, H.; Altun, B.; Unal, S. (2013)
    Background: In the past, Staphylococcus aureus infections have displayed various patterns of epidemiologic curves in hospitals, particularly in intensive care units (ICUs). This study aimed to characterize the current trend ...
  • Colistin nephrotoxicity increases with age 
    Balkan, I.I.; Dogan, M.; Durdu, B.; Batirel, A.; Hakyemez, I.N.; Cetin, B.; Karabay, O.; Gonen, I.; Ozkan, A.S.; Uzun, S.; Demirkol, M.E.; Akbas, S.; Kacmaz, A.B.; Aras, S.; Mert, A.; Tabak, F. (2014)
    Background: Colistin (COL) has become the backbone of the treatment of infections due to extensively drug-resistant (XDR) Gram-negative bacteria. The most common restriction to its use is acute kidney injury (AKI). Methods: ...
  • Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort 
    Idilman, R.; Demir, M.; Aladag, M.; Erol, C.; Cavus, B.; Iliaz, R.; Koklu, H.; Cakaloglu, Y.; Sahin, M.; Ersoz, G.; Koksal, İ.; Karasu, Z.; Ozgenel, M.; Turan, İ.; Gunduz, F.; Ataseven, H.; Akdogan, M.; Kiyici, M.; Koksal, A.S.; Akhan, S.; Gunsar, F.; Tabak, F.; Kaymakoglu, S.; Akarca, U.S.; Early Access Program (EAP) Study Group (2019)
    The aims of the present study were to evaluate the efficacy and tolerability of ledipasvir/sofosbuvir (LDV/SOF) with or without ribavirin in the treatment of chronic hepatitis C (CHC) in patients with advanced liver disease ...
  • The Bad Bug is Back: Acinetobacter Baumannii Bacteremia Outbreak during the COVID-19 Pandemic in an Intensive Care Unit 
    Mete, B.; Kurt, A.F.; Urkmez, S.; Demirkiran, O.; Can, G.; Dumanli, G.Y.; Bozbay, S.; Arsu, H.Y.; Otlu, B.; Karaali, R.; Balkan, I.I.; Saltoglu, N.; Dikmen, Y.; Tabak, F.; Aygun, G. (2022)
    Background: Epidemiology of nosocomial infections may show variability because of under-estimation of infection control measures (ICMs) in coronavirus disease 19 (COVID-19) outbreak. Aim: To investigate the Acinetobacter ...